Amiodarone and disk edema: Physiopathological debate based on a case report;Amiodarone et œdème papillaire: Problégmes physiopathogéniques á travers un cas

Journal Francais d'Ophtalmologie

Volumn 26, Issue 2, 2003, Pages 182-186

  Ait Ali F ^a   Grolleau Raoux, F ^b   Arnaud, B ^a   Schmitt Bernard, C F ^c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b Forum Medica   (France)

^c Antigone Ophtalmologie   (France)

Author keywords

Amiodaron; Disk edema; Optic neuropathy; Papillary disease; Pseudotumor cerebri

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; BRAIN PSEUDOTUMOR; CASE REPORT; FLUOROGRAPHY; FOLLOW UP; HUMAN; MALE; NEUROPATHY; OPTIC NERVE DISEASE; PAPILLEDEMA; PERIMETRY; VASCULARIZATION; CHEMICALLY INDUCED DISORDER;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; HUMANS; MALE; PAPILLEDEMA;

EID: 0142168029     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Leifert D, Hansen LL ILL, Gerling J. Amiodarone-associated optic neuropathy: an Independent syndrome? Three patients with bilateral optic neuropathy. Klin Monatsbl Augenheilkd, 2000;217:171-7.
2. Speicher MA, Goldman MH, Chrousos GA. Amiodarone optic neuropathy without disc edema. J Neuro Ophthalmol, 2000;20:171-2.
3. Eryilmaz T, Atilla H, Batioglu F, Gunalp I. Amiodarone-related optic neuropathy. Jpn J Ophthalmol, 2000;44:565-8.
4. Bartolucci J, Ibanez P, Verdugo C, Fuentes R, Arriagada G, Torres J. Amiodarone induced retrobulbar neuritis. Clinical case. Rev Med Chil, 1999;127:827-30.
5. Sreih AG, Schoenfeld MH, Marieb MA. Optic neuropathy following amiodarone therapy. Pacing Clin Electrophysiol, 1999;22:1108-10.
6. Gobbele R, Dahlke C, Mull M, Schwarz M. Amiodarone-induced bilateral optic atrophy: a case report. Nervenarzt, 1999;70:560-5.
7. Macaluso DC, Shults VVT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol, 1999;127:610-2.
8. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol, 1998;42:360-6.
9. Ingram DV, Jaggarao NS, Chamberlain DA. Ocular changes resulting from therapy with amiodarone. Br J Ophthalmol, 1982;66:676-9
10. Krieg P, Schipper I. Bilateral optic neuropathy following amiodarone therapy. Klin Monatsbl Augenheilkd, 1992;200:128-32.
11. Belec L, Davila G, Bleibel JM, Azoulay A, Laloun L, Poisson M. Bilateral optic neuropathy during prolonged treatment with amiodarone. Ann Med Interne, 1992;143:349-50.
12. Ferreiro JL, Isern Longares JA, Ramon Moya AF. Optic neuropathy caused by amiodarone Neurologia, 1990;5:160-3.
13. Younge BR. Amiodarone optic neuropathy. J Clin Neuroophthalmol, 1988;8:29.
14. Nazarian SM, Jay WM. Bilateral optic neuropathy associated with amiodarone therapy J Clin Neuro Ophthalmol, 1988;8:25-8.
15. Feiner LA, Younge BR, Kazmier JF, Stricker BH, Fraundfelder FT. Optic neuropathy and amiodarone therapy. Mayo Clin Proc, 1987;62:702-17.
16. Gittinger JW Jr, Asdourian GK. Papillopathy caused by amiodarone. Arch Ophthalmol, 1987;150:349-51.
17. Naccarelli GV, Rinkenberger RL, Dougherty AH, Giebel RA. Amiodarone: pharmacology, and antiarrhythmic and adverse effects. Pharmacotherapy, 1985;5:298-313.
18. Ahmad S. Amiodarone and reversible benign intracranial hypertension. Cardiology, 1996;87:90.
19. Borruat FX, Regli F. Pseudotumor cerebri as a complication of amiodarone therapy. Am J JI Ophthalmol, 1993; 116:776-7.
20. Grogan WA, Narkun DM. Pseudotumor cerebri with amiodarone arniodarone. J Neurol Neurosurg Psychiatry, 1987;50:651.
21. Van Zandijcke M, Dewachter A. Pseudotumor cerebri with amiodarone. J Neurol Neurosurg Psychiatry, 1986;49:1463-4.
22. Fikkers BG, Bogousslavsky J, Regli F, Glasson S. Pseudotumor cerebri with amiodarone. J Neurol Neurosurg Psychiatry, 1986;49:606.
23. Cordon Lopez A, Munoz Lopez A, Fernandez Jimenez S, Ruiz de EIvira MJ. Acute intracranial hypertension during amiodarone infusion. Crit Care Med, 1985;13:688-9.,
24. Mansour AM, Puklin JE, O'Grady R. Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol, 1988;8:231-7.